Related Experiment Video

Updated: Apr 19, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.9K

When will resistance be futile?

Katherine L B Borden1

  • 1Department of Pathology and Cell Biology, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. katherine.borden@umontreal.ca.

Cancer Research
|December 6, 2014
PubMed

Insights

Cancer cells develop drug resistance through inducible drug glucuronidation, driven by Gli1 and UGT1A enzymes. Inhibiting Gli1 restores drug sensitivity, offering new strategies against cancer treatment failure.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Cancer cells develop resistance to chemotherapy drugs.
  • Existing strategies to overcome drug resistance are insufficient for durable treatment.
  • Inducible drug modifications represent a significant challenge in cancer therapy.

Purpose of the Study:

  • To investigate a novel form of multidrug resistance: inducible drug glucuronidation.
  • To explore the role of eukaryotic translation initiation factor 4E (eIF4E) and its inhibitor ribavirin in cancer.
  • To understand the mechanisms underlying relapse in patients treated with ribavirin.

Main Methods:

  • Clinical studies involving ribavirin treatment for cancer patients.
  • Investigating the role of the sonic hedgehog transcription factor Gli1 and UDP glucuronsyltransferase (UGT1A) enzymes.
  • Assessing the impact of Gli1 inhibition on drug metabolism and sensitivity.

Main Results:

  • Ribavirin treatment initially showed clinical responses but patients relapsed due to drug resistance.
  • Overexpression of Gli1 led to elevated UGT1A enzymes, causing drug glucuronidation and resistance to ribavirin and Ara-C.
  • Inhibition of Gli1 reduced UGT1A levels, decreased drug glucuronides, and restored sensitivity to chemotherapy.

Conclusions:

  • Cancer cells metabolize drugs differently than normal cells, particularly under resistance conditions.
  • Inducible drug glucuronidation, mediated by Gli1 and UGT1As, is a key mechanism of acquired multidrug resistance.
  • Targeting Gli1 and understanding inducible drug modifications are crucial for developing effective, durable cancer treatments.

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

8.5K
Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

12.6K

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
62.4K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
165
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
94
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
82